PROTAC ALK degrader-3
PROTAC ALK degrader-3 is an orally active ALK PROTAC degrader with a DC50 of 119.33 nM in Karpas 299 cells. PROTAC ALK degrader-3 induces the degradation of ALK fusion proteins via the ubiquitin-proteasome system. PROTAC ALK degrader-3 induces NPM-ALK degradation and inhibits the expression of p-ALK and p-STAT3. PROTAC ALK degrader-3 inhibits cancer cell proliferation and suppresses the growth of xenografts in vivo. PROTAC ALK degrader-3 can be used for the research of ALK-positive cancers (e.g., anaplastic large cell lymphoma).
(Pink: Anaplastic lymphoma kinase (ALK) ligand (HY-168552); Blue: Cereblon ligand (HY-W023573); Black: linker (HY-15656)).
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 分子式: C50H60ClN9O7S
- 分子量:966.59
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
PROTACs アイソフォーム固有の製品をすべて表示
More
生物活性
製品説明
IC50 & Target
[1]|
Cereblon |
p-STAT3 |
体外実験
PROTAC ALK degrader-3 (20-1000 nM; 3-48 h) induces concentration-dependent degradation of NPM-ALK in Karpas 299 cells, with a DC50 of 119.33 nM and a Dmax of 97.1%[1].
PROTAC ALK degrader-3 (20-200 nM; 3-48 h) induces degradation of NPM-ALK, inhibition of p-ALK, and over 80% inhibition of p-STAT3 without altering total STAT3 levels in Karpas 299 cells[1].
PROTAC ALK degrader-3 (200 nM; 2 h pretreatment followed by 24 h co-treatment) induces degradation of NPM-ALK in Karpas 299 cells via the ubiquitin-proteasome system, and this process depends on the binding of CRBN E3 ligase to ALK[1].
PROTAC ALK degrader-3 (72 h) inhibits the proliferation of Ba/F3-EML4-ALK wild-type and mutant cell lines (C1156Y, L1196M, G1202R, G1202R-L1196M) with IC50 values ranging from 27.25 nM to 215.2 nM, and shows no activity against parental Ba/F3 cells[1].
PROTAC ALK degrader-3 (20-500 nM; 48 h) induces 52% degradation of EML4-ALKG1202R[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:Karpas 299 cells
-
Concentration:20, 50, 100, 200, 500, 1000 nM
-
Incubation Time:48 h
-
Result:Induced concentration-dependent degradation of NPM-ALK protein, with a DC50 of 119.33 nM and a maximum degradation (Dmax) of 97.1%.
Showed no "hook effect" up to 1000 nM.
-
Cell Line:Karpas 299 cells
-
Concentration:200 nM
-
Incubation Time:3, 6, 12, 24, 48 h
-
Result:Induced significant NPM-ALK degradation (>50%) within 12 h of treatment.
-
Cell Line:Karpas 299 cells
-
Concentration:20, 50, 100, 200 nM
-
Incubation Time:48 h
-
Result:Exhibited concentration-dependent degradation of NPM-ALK and inhibition of p-ALK.
Inhibited p-STAT3 by over 80% at 100 nM without significantly affecting total STAT3 levels.
-
Cell Line:Karpas 299 cells
-
Concentration:200 nM
-
Incubation Time:24 h pre-treatment, followed by 3, 6, 12, 24, 48 h in drug-free medium
-
Result:Reduced NPM-ALK levels to 15% after 24 h treatment, with no recovery observed over 48 h of drug washout.
Decreased p-ALK levels to 32% and remained low over 48 h of drug washout.
Reduced p-STAT3 levels to 5% with no significant recovery over 48 h of drug washout.
-
Cell Line:Ba/F3-EML4-ALK-G1202R cells
-
Concentration:20, 100, 500 nM
-
Incubation Time:48 h
-
Result:Induced 52% degradation of EML4-ALK-G1202R at 500 nM.
Parmacokinetics
体内実験
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:NSG mice (female, 4-6 weeks old)[1]
-
Dosage:25 mg/kg; 50 mg/kg
-
Administration:p.o.; daily
-
Result:Achieved a tumor growth inhibition (TGI) of 30.1%.
Achieved a tumor growth inhibition (TGI) of 49.5%.
Caused no significant side effects or weight loss during treatment.
- RNA extraction experimental
- BrdU Incorporation Assay
- Somatic Cell Culture
- CFSE Dye Dilution Proliferation Assay
- Dye-dilution cell tracking and proliferation staining
- CCK-8/WST-8 Cell Proliferation Assay
- Protocol for Cell Cycle
- Cell Counting-Based Growth Curve Assay
- Colony Formation (Clonogenic) Assay
- Cell Viability Determination by MTT Colorimetric Assay
- EdU Incorporation Assay (Click Chemistry-Based DNA Synthesis Measurement)
- Ki-67 Immunostaining Proliferation Assay
- PCNA Immunodetection Proliferation Assay
- Protocol for Cell Counting and Cell Density Analysis
- MTT Cell Proliferation Assay
化学情報
-
分子量 966.59
-
分子式 C50H60ClN9O7S
-
SMILES
CC1=C(C=C(C(NC2=NC=C(C(NC3=CC=CC=C3S(=O)(C(C)C)=O)=N2)Cl)=C1)OC(C)C)C4CCN(CC4)C5CN(C5)C6CCC(CC6)NC7=CC=C8C(N(C(C8=C7)=O)C9CCC(NC9=O)=O)=O
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
Keywords
- PROTAC ALK degrader-3
- PROTAC ALK degrader3
- PROTAC ALK degrader 3
- PROTACs
- Anaplastic lymphoma kinase (ALK)
- STAT
- PROTAC
- Anaplastic lymphoma kinase
- ALK tyrosine kinase receptor
- CD246
- Cluster of differentiation 246
- ALK G1202R-resistant cells
- p-STAT3
- ALK-positive cancers
- CRBN E3 ligase
- Karpas 299 cells
- ALK fusion protein
- ubiquitin proteasome system
- NPM-ALK
- p-ALK
- Ba/F3-EML4-ALK
- Inhibitor
- inhibitor
- inhibit